SCHEMBL19652004

SCHEMBL19652004

Cc1ccc(N(c2ccc(Cl)cc2)c2ccc(C=C3C(=O)N(C)C(=S)N(C)C3=O)o2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 15/20 0.63
KMT2A Q03164 12/20 0.63
MEN1 O00255 11/20 0.63
RAB9A P51151 4/20 0.63
SMN1; SMN2 Q16637 3/20 0.63
NPC1 O15118 3/20 0.48
IDE P14735 1/20 0.48
ALDH1A1 P00352 11/20 0.45
POLB P06746 4/20 0.45
CYP1A2 P05177 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
THRB P10828 1/20 0.45
NPSR1 Q6W5P4 3/20 0.44
GFER P55789 1/20 0.44
CRHBP P24387 1/20 0.44
CRHR2 Q13324 1/20 0.44
HPGD P15428 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19652025 0.94 MAPT (0.70) MAPTKMT2AMEN1RAB9ASMN1; SMN2
SCHEMBL19652009 0.86 MAPT (0.58) MAPTKMT2AMEN1RAB9ASMN1; SMN2
SCHEMBL19652021 0.83 MAPT (0.72) MAPTKMT2AMEN1RAB9ASMN1; SMN2
SCHEMBL19652003 0.76 MAPT (0.47) MAPTKMT2AMEN1RAB9ASMN1; SMN2
SCHEMBL18882576 0.76 KMT2A (0.44) MAPTKMT2AMEN1RAB9ASMN1; SMN2
SCHEMBL25870721 0.75 CISD1 (0.36) MAPTKMT2AMEN1RAB9ASMN1; SMN2
SCHEMBL19652012 0.72 MAPT (0.51) MAPTKMT2AMEN1RAB9ASMN1; SMN2
SCHEMBL18882628 0.70 KMT2A (0.47) MAPTKMT2AMEN1RAB9ASMN1; SMN2
SCHEMBL18863387 0.69 CISD1 (0.39) MAPTKMT2AMEN1RAB9ASMN1; SMN2
SCHEMBL18882565 0.69 MAPT (0.43) MAPTKMT2AMEN1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9960362-B2 Compound and organic photoelectric device, image sensor and electronic device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2018-05-01 US disclosed
US-9960362-B2 Compound and organic photoelectric device, image sensor and electronic device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2018-05-01 US disclosed
US-20170346016-A1 COMPOUND AND ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR AND ELECTRONIC DEVICE INCLUDING THE SAME Samsung Electronics Co .. Ltd. (KR) 2017-11-30 US disclosed
US-20170346016-A1 COMPOUND AND ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR AND ELECTRONIC DEVICE INCLUDING THE SAME Samsung Electronics Co .. Ltd. (KR) 2017-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170346016-A1 COMPOUND AND ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR AND ELECTRONIC DEVICE INCLUDING THE SAME PPOX, PIEZO1, CYP1A1 MAPT 2370/4885KMT2A 1370/4885MEN1 1455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.